文献速递运动医学关节外科

关节镜下肩袖修复术中骨髓刺激:随机对照试验的荟萃分析

Bone Marrow Stimulation for Arthroscopic Rotator Cuff Repair: A Meta-analysis of Randomized Controlled Trials.
PubMed 文献 · Am J Sports Med · 2024-02-08

该荟萃分析纳入7项随机对照试验共576例患者,比较关节镜下肩袖修复术中行骨髓刺激与对照组的疗效。结果显示骨髓刺激组与对照组在再撕裂率(18.8% vs 21.0%,I²=43%,P=0.61)、Constant评分(88.2 vs 86.7,P=0.12)、美国肩肘外科医师评分(94.3 vs 93.2,P=0.31)及视觉模拟评分(0.9 vs 0.9,P=0.89)上均无显著差异。证据水平为1级的文献不支持骨髓刺激作为改善关节镜下肩袖修复术后再撕裂率或临床结局的方法。

要点

  • 骨髓刺激组再撕裂率18.8%,对照组21.0%,差异无统计学意义(I²=43%,P=0.61)。
  • 骨髓刺激组与对照组Constant评分分别为88.2和86.7,差异无统计学意义(P=0.12)。
  • 美国肩肘外科医师评分(94.3 vs 93.2,P=0.31)和视觉模拟评分(0.9 vs 0.9,P=0.89)均无显著差异。

核心结论

  • 证据水平为1级的文献不支持骨髓刺激作为改善关节镜下肩袖修复术后再撕裂率或临床结局的方法。

研究设计与样本

  • 荟萃分析,证据水平为1级,纳入7项随机对照试验共576例患者。
  • 依据PRISMA指南对3个数据库进行文献检索,纳入比较骨髓刺激与对照组的关节镜下肩袖修复随机对照试验。

主要发现

  • 骨髓刺激组再撕裂率为18.8%,对照组为21.0%(I²=43%,P=0.61)。
  • 骨髓刺激组平均Constant评分为88.2,对照组为86.7(P=0.12)。
  • 骨髓刺激组与对照组美国肩肘外科医师评分分别为94.3和93.2(P=0.31)。
  • 骨髓刺激组与对照组视觉模拟评分分别为0.9和0.9(P=0.89)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bone marrow stimulation (BMS) has been proposed to augment healing at the time of arthroscopic rotator cuff repair (ARCR) by creating several bone marrow vents in the footprint of the rotator cuff, allowing mesenchymal stem cells, platelets, and growth factors to cover the area as a "crimson duvet." PURPOSE: To perform a meta-analysis of randomized controlled trials (RCTs) to compare the outcomes after BMS and a control for those undergoing ARCR. STUDY DESIGN: Meta-analysis; Level of evidence, 1. METHODS: A literature search of 3 databases was performed based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. RCTs comparing BMS and a control for ARCR were included. Clinical outcomes were compared, and a P value <.05 was considered to be statistically significant. RESULTS: A total of 7 RCTs with 576 patients were included. Overall, 18.8% of patients treated with BMS and 21.0% of patients treated with a control had a retear (I2 = 43%; P = .61). With BMS, the mean Constant score was 88.2, and with the control, the mean Constant score was 86.7 (P = .12). Additionally, there was no significant difference in the American Shoulder and Elbow Surgeons score (94.3 vs 93.2, respectively; P = .31) or visual analog scale score (0.9 vs 0.9, respectively; P = .89). CONCLUSION: The level 1 evidence in the literature did not support BMS as a modality to improve retear rates or clinical outcomes after ARCR.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Hurley ET, Crook BS, Danilkowicz RM, et al. Bone Marrow Stimulation for Arthroscopic Rotator Cuff Repair: A Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2024. PMID: 38328818. doi:10.1177/03635465231213873

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。